WASHINGTON (Washington Insider Magazine) – Pfizer requested emergency use clearance for its vaccination for children under the age of five from the Food and Drug Administration on Tuesday.
The FDA will now analyze the data, present it to its independent advisers, and perhaps approve the vaccine in the following weeks as a result of this action. On February 15, the FDA’s independent advisers will hold a public hearing.
According to ABC NEWS, the data would next be presented to the Centers for Disease Control and Prevention’s independent experts for yet another review, followed by a possible recommendation from CDC Director Rochelle Walensky, all of which could happen within the month.
Pfizer’s 2 dose vaccine is currently available to everyone over the age of five. Anyone above the age of 12 can get a booster shot after 5 months. Adults can purchase Johnson & Johnson and Moderna.
In December, Pfizer revealed that their vaccination for children under the age of five had been shown to be safe and effective, but that the 2 dose schedule wasn’t as successful for children aged 2, 3, and 4 as it was for adults. The dose for children under the age of five is one-tenth that for adults.
Pfizer filed data for 2 doses of the vaccine again on Tuesday, but with the assumption that data for a three-dose vaccination will be available soon, making it more efficient at preventing sickness.
In March or April, Pfizer is expected to have more evidence on the effectiveness of a three-dose regimen, but allowing the first 2 doses in February would allow the immunization process to begin sooner.
After the second treatment, the third dose will be given at least 8 weeks later.
According to a recent weekly report from the American Academy of Pediatrics (AAP) and the Children’s Hospital Association, roughly 808,000 children tested positive for COVID-19 last week, down from a peak of 1,150,000 reported the week ending Jan. 20. (CHA).
Since the beginning of the epidemic, 11.4 million youngsters have tested positive for the virus. In the omicron variant outbreak, child COVID-19 cases “spiked substantially,” with far more than 3.5 million reported cases in January.
Unvaccinated 12 to 17-year-olds had an 11-fold higher risk of hospitalization than fully vaccinated youngsters, according to the CDC.
While it is less likely for young children to end up in the hospital, it is nevertheless conceivable. They can also act as spread vectors, infecting other adults in their group who are at higher risk.
